Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
ADVANZ PHARMA
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:fate |
acquired
|
| gptkbp:focusesOn |
cardiovascular diseases
|
| gptkbp:formerName |
Cardiome Pharma Corp.
|
| gptkbp:foundedYear |
1992
|
| gptkbp:headquartersLocation |
gptkb:Vancouver,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Correvio
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Brinavess
Xydalba Aggrastat Zevtera/Mabelio |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
CORV
|
| gptkbp:bfsParent |
gptkb:Brinavess
|
| gptkbp:bfsLayer |
6
|